We now know that even identical genes are expressed differently in males and females, making it even more crucial than we originally thought to consider the impact of sex on genomic manipulation. For example It is already clear that sex of the recipient and that of the donor impact outcome. Work on chimeras, in which tissues or cells from one species are implanted into another must consider sex as a variable in research protocols. The physiology of males and females is significantly different and researchers must assess the impact of gender on the data they harvest from such preparations. Similarly, work on artificial intelligence should take into account what we already know about the differences in the anatomy, chemistry and function of male and female brains.
Gender-specific medicine allows us to develop comprehensive, evidence-based, and unique educational programs that communicate the new knowledge to both healthcare professionals and the public. The FGSM envisions a time when gender-specific medicine will no longer be considered a specialty but instead will become an integrated aspect within all specialties of science and medicine.